JB

Jennifer Bath

President and CEO

IPA (ImmunoPrecise Antibodies)

Minneapolis, Minnesota


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
IPA (ImmunoPrecise Antibodies)
Industry
research
Employees
90.0
Seniority
C suite
Annual Revenue
18952000.0

Professional Summary

Jennifer Bath serves as President and CEO at IPA (ImmunoPrecise Antibodies). IPA (ImmunoPrecise Antibodies) operates in the research sector with approximately 90.0 employees. The company is headquartered in Minneapolis, Minnesota. IPA (ImmunoPrecise Antibodies) generates annual revenue of 18952000.0.

Industry & Role Insights

  • MessageCEO tracks 2,961 executives in the research sector.
  • 1,832 executive contacts are available in Minnesota.
  • Our database includes 201,469 c suite-level executives.

Technologies

NetSuite Mailchimp Mandrill Outlook MailChimp SPF CloudFlare Hosting Microsoft Office 365 Amazon AWS Hubspot Pardot FullStory Vimeo Google Analytics DoubleClick DoubleClick Conversion Mobile Friendly Linkedin Marketing Solutions WordPress.org Google Dynamic Remarketing Woo Commerce Google Tag Manager Adobe Media Optimizer Cedexis Radar reCAPTCHA Stripe Twitter Advertising AI Android Python

Keywords

hybridoma sequencing hybridoma development rabbit monoclonals cryostorage antibody generation antibody purifcation polyclonal production peptide production human antibodies recombinant protein b cell phage display ai antibody discovery biotechnology: pharmaceutical preparations health care biotechnology research antibody characterization developability profiling optimization engineering preclinical services protein production target analysis immunization technologies b cell select monoclonal antibodies recombinant proteins immunogenicity screening bispecific antibodies ai technology lens ai transgenic animal models epitope mapping affinity maturation humanization of antibodies high-affinity antibodies lab automation biologics development clinical trial support hybridoma technology antigen design protein expression in-silico modeling antibody libraries cross-reactiveness testing biotherapeutics drug development services high-throughput screening hybridoma cell lines bioinformatics solutions molecular characterization custom assay development cell line development antibody engineering purification processes assay validation drug delivery systems function-first approach clinical success metrics data-driven discovery health wellness & fitness

Related Executives

SN
Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.
SD
Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.
M
Mark Chief Executive Officer at 23Strands
IT
Ilia Tikhomirov Chief Executive Officer at 35Pharma
AD
Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Frequently Asked Questions

How can I contact Jennifer Bath?

Jennifer Bath's verified email address is available on MessageCEO. They currently work at IPA (ImmunoPrecise Antibodies). Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Jennifer Bath lead?

Jennifer Bath is President and CEO at IPA (ImmunoPrecise Antibodies), a company in the research sector with 90.0 employees. The company is based in Minneapolis, Minnesota.

What industry is Jennifer Bath in?

Jennifer Bath works in the research industry as President and CEO at IPA (ImmunoPrecise Antibodies). MessageCEO provides verified contact information for executives across all major industries.

Is Jennifer Bath's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Jennifer Bath's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: April 8, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans